- $118.57m
- $57.63m
- $194.06m
Brief: LifeMD Expects To File Form 12B-25, Notifying US SEC Of Late Filing Of Form 10-Q For Period Ended September 30, 2025
Factbox: Pharma companies announce direct-to-consumer sales and price cuts in US
Factbox: Pharma companies announce direct-to-consumer sales and price cuts in US
Factbox: Big pharma firms announce direct-to-consumer sales and price cuts in U.S.
U.S. STOCKS ON THE MOVE-General Motors, CoreWeave , Gold Miners
LifeMD climbs after offering Novo's Ozempic at $499 a month
LifeMD to offer Novo's Ozempic at $499 a month to eligible US cash-paying customers (updated)
LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers
U.S. STOCKS ON THE MOVE-Novavax, copper miners, Apple
U.S. STOCKS ON THE MOVE-Novavax, Copper miners, Apple
LifeMD slumps after firm cuts 2025 revenue forecast
LifeMD Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: LifeMD Q2 Revenue USD 62.2 Million Vs. IBES Estimate USD 66.3 Million
LifeMD Inc expected to post a loss of 1 cent a share - Earnings Preview
Novo Nordisk says WeightWatchers will sell Wegovy, announces $299 price (updated)
Timeline: From insulin to Ozempic, history of Novo Nordisk's CEOs
LifeMD Inc reports results for the quarter ended March 31 - Earnings Summary
LifeMD Inc expected to post a loss of 5 cents a share - Earnings Preview
Hims & Hers rises after plan to sell Eli Lilly's weight loss drug on its platform